Brentuximab Intravenous and Lanoxin Pediatric Intravenous
Determining the interaction of Brentuximab Intravenous and Lanoxin Pediatric Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: digoxin
Brand name: Lanoxin, Digitek, Digox, Lanoxicaps, Cardoxin
Synonyms: Lanoxin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-Lanoxin Tablets
- Brentuximab Intravenous-Lanreotide
- Brentuximab Intravenous-Lanreotide Acetate
- Brentuximab Intravenous-Lanreotide Subcutaneous
- Brentuximab Intravenous-Lansoprazole
- Brentuximab Intravenous-Lansoprazole Delayed-Release Capsules
- Lanoxin Pediatric Intravenous-Brentuximab vedotin
- Lanoxin Pediatric Intravenous-Breo Ellipta
- Lanoxin Pediatric Intravenous-Brethine
- Lanoxin Pediatric Intravenous-Brethine Subcutaneous
- Lanoxin Pediatric Intravenous-Bretylium
- Lanoxin Pediatric Intravenous-Bretylium Injection